Former US President Donald Trump said the “truce” with Iran was “over,” escalating geopolitical tensions. India’s Nifty-50 and BSE Sensex each fell more than 2% in a single session, underperforming most major global benchmarks, with only South Korea’s Kospi posting a larger decline. The article argues Indian equities tend to react more sharply to external geopolitical shocks, forming a recurring pattern.

From after the close on July 17 through July 18, companies representing roughly 35% of the Nifty 50 index weight are set to report results for the June 2024 quarter, including Reliance Industries (9%), HDFC Bank (11.39%), ICICI Bank (9.05%), Axis Bank (3.43%), Kotak Mahindra Bank (~2%) and Yes Bank. With the exception of ICICI Bank, the banks have issued positive business updates for the quarter, though Kotak Mahindra Bank’s provisional numbers prompted a decline in its shares. Investors are focused on asset quality, net interest margins and the use of the FCNR(B) window, making the reporting cluster a near-term price driver for both the Nifty 50 and Nifty Bank indices.

Dateline Resources Ltd (ASX: DTR) rose 33.33% to 18 cents after the US Department of Justice filed documents opposing a legal challenge tied to its Colosseum gold and rare earths project in California. The DOJ said the National Park Service’s April 2025 letter merely confirmed existing mining rights rather than granting a new approval, and argued laws introduced in 1994 protect the project’s approved mine plan. Colosseum is the company’s key asset, with its bankable feasibility study estimating a pretax value of US$785 million and an IRR of 49.5%. The filing reduces a central legal uncertainty, though the court will still decide the case.

Brent has fallen from an April peak of $120 to about $78, rebounding from a $72 low. Analysts say India’s state-owned oil marketing companies could see integrated margins of ₹26–₹27 per litre—about double the historical average—so long as Brent stays below $80. At that run rate, annualised integrated profit is estimated at ₹4 lakh crore versus a normalised ₹1.8 lakh crore. OMC under-recoveries totalled ₹2.2 lakh crore as of June 30, and could be recovered in nearly 12 months if crude prices and refining margins hold.

Vikran Engineering’s board has approved providing corporate guarantees of up to ₹3,400 Crores and a promoter fund infusion of up to ₹1,160 Crores to its wholly owned subsidiaries to support operations and solar project financing. The arrangements are subject to bank credit approvals and will be treated as a contingent liability, with no immediate cash outflow or profit-and-loss impact expected. The company said the disclosures were made under SEBI’s listing regulations and that related-party transactions will be carried out on an arm’s-length basis.

Goodluck India’s board approved a 2:1 bonus issue of about 6,64,77,018 shares, revised its final dividend for the year ended March 31, 2026 to Re 1.00 per share, and cleared a ₹275 crore corporate guarantee for a subsidiary’s project loan. Its subsidiary Goodluck Defence and Aerospace Limited also secured a domestic order worth approximately Rs 255 crore for 155mm long range empty shells, with execution scheduled within 10 months. The developments represent material progress in operations and capital actions at the company level. They are expected to support the stock’s valuation and market sentiment.

SBI Funds Management has launched a roughly Rs 9,813 crore IPO that is entirely an offer for sale, meaning the company will not receive any proceeds. The issue is priced at Rs 545–574 per share, implying a valuation of about Rs 1.17 lakh crore. As India’s largest asset manager, it reports QAAUM of Rs 12.5 lakh crore and a 15.4% market share. Brokerages have largely recommended subscribing, while highlighting active fund performance and market conditions as key monitorables.

MeCure Industries reported 2025 results showing revenue of N77.69 billion, up 69%, with EBIT of N16.43 billion, up 98%, and profit after tax of N6.46 billion, up 177%. The company said it secured approvals for 19 new medicines and expanded into Sierra Leone. Shareholders approved a dividend of 32 kobo per share and agreed to increase the company’s capital-raising plan to N50 billion from N30 billion.